CD8+CD25+FoxP3+ cells are significantly elevated in blood and tissue of CRC patients, and exhibit suppressive activity against CD4+CD25− T-cell proliferation and Th1-cytokine production [3,4]. This evidence concerns the gene FOXP3 and colorectal carcinoma.